VVD-214
| Clinical data | |
|---|---|
| Drug class | WRN helicase inhibitor |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C20H21F2N3O4S |
| Molar mass | 437.46 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
VVD-214 (RO7589831) is a drug which acts as an inhibitor of the enzyme WRN helicase. It is being researched for the treatment of microsatellite instability high forms of cancer.[1][2]
References
- ^ Kikuchi S, Green JC, Rogness DC, Lam B, Owyang ZA, Malmstrom RD, et al. (December 2025). "Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers". Journal of Medicinal Chemistry. 68 (24): 25912–25938. doi:10.1021/acs.jmedchem.5c01805. PMC 12751020. PMID 40964743.
- ^ Baltgalvis KA, Lamb KN, Symons KT, Wu CC, Hoffman MA, Snead AN, et al. (May 2024). "Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase". Nature. 629 (8011): 435–442. doi:10.1038/s41586-024-07318-y. PMID 38658751.